Skip to main content
OpenTrials

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

2,207 public trials 376 recruiting studies
Refine in advanced search Browse all conditions

Melanoma trial results

Active, Not Recruiting

Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma

NCT04674683

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +17 more
Locations
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Innovative Clinical Research Institute (ICRI) Pasadena, California, United States
  • Emad Ibrahim, MD, INC Redlands, California, United States
View all 139 locations
View Trial Details
Active, Not Recruiting

A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)

NCT05933577

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Highlands Oncology Group ( Site 1943) Springdale, Arkansas, United States
  • UCLA Hematology/Oncology - Westwood (Building 100) ( Site 1918) Los Angeles, California, United States
  • UCSF Medical Center at Mission Bay ( Site 1929) San Francisco, California, United States
  • Yale-New Haven Hospital-Yale Cancer Center ( Site 1933) New Haven, Connecticut, United States
View all 165 locations
View Trial Details
Active, Not Recruiting

A Single Arm Trial Evaluating the Efficacy and Safety of EVX-01 in Combination With Pembrolizumab in Adults With Unresectable or Metastatic Melanoma

NCT05309421

Conditions
Melanoma, Melanoma Stage IV, Neoplasms, +11 more
Locations
  • Melanoma Institute Australia Wollstonecraft, New South Wales, Australia
  • One Clinical Research Nedlands, Western Australia, Australia
  • Divisione di Oncologia Medica del Melanoma Milan, Italy
  • Instituto Nazionale Tumori IRCCS Fondazione Naples, Italy
View Trial Details
Active, Not Recruiting

A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors

NCT05653882

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +36 more
Locations
  • City of Hope Duarte, California, United States
  • UCLA Los Angeles, California, United States
  • UCSD San Diego, California, United States
  • UCSF San Francisco, California, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma

NCT03470922

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Local Institution - 0010 Tucson, Arizona, United States
  • Local Institution - 0020 Los Angeles, California, United States
  • Coastal Integrative Cancer Care San Luis Obispo, California, United States
  • Local Institution - 0116 Santa Barbara, California, United States
View all 127 locations
View Trial Details
Active, Not Recruiting

Assessment of PK Similarity of FYB206 in Comparison With Keytruda in Resected Stage II or III Melanoma Patients

NCT06551064

Conditions
Melanoma, Melanoma Stage III, Melanoma, Stage II, +11 more
Locations
  • Formycon Investigative Site Sarajevo, Bosnia and Herzegovina
  • Formycon Investigative Site Sofia, Bulgaria
  • Formycon Investigative Site Tartu, Estonia
  • Formycon Investigative Site Batumi, Georgia
View all 17 locations
View Trial Details
Active, Not Recruiting

IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)

NCT05155254

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +11 more
Locations
  • Mid Florida Hematology and Oncology Center Orange City, Florida, United States
  • Orlando Health Cancer Institute Orlando, Florida, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • VCU Massey Cancer Center Richmond, Virginia, United States
View all 112 locations
View Trial Details
Active, Not Recruiting

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

NCT05864144

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +101 more
Locations
  • UCLA Hematology/Oncology Los Angeles, California, United States
  • University of Colorado Cancer Center - Anschutz Medical Aurora, Colorado, United States
  • Norton Healthcare Louisville, Kentucky, United States
  • Henry Ford Cancer Detroit, Michigan, United States
View Trial Details

Related conditions